(Q71542483)
Statements
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma (English)
Murray JL
Kleinerman ES
Jia SF
Rosenblum MG
Buzaid A
Legha S
Ross MI
Thompson L
Mujoo K
Rieger PT
Saleh M
Khazaeli MB
Vadhan-Raj S